Long-term survival after pancreatic resection for renal cell carcinoma metastasis
| Autor: | Jean-François Gigot, Alain Sauvanet, N. Regenet, J.-Y. Mabrut, L. Schwarz, Brice Gayet, E Housseau, Jean-Jacques Tuech, Bertrand Millat, Mehdi Ouaissi, David Fuks |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Adult
Male medicine.medical_specialty Metastasis Surgical oncology Renal cell carcinoma medicine Carcinoma Humans Lymph node Survival rate Carcinoma Renal Cell Aged Neoplasm Staging Retrospective Studies business.industry Retrospective cohort study Middle Aged medicine.disease Prognosis Primary tumor Carcinoma Papillary Kidney Neoplasms Surgery Pancreatic Neoplasms Survival Rate medicine.anatomical_structure Oncology Female Neoplasm Recurrence Local business Follow-Up Studies |
| Zdroj: | Annals of surgical oncology. 21(12) |
| ISSN: | 1534-4681 |
| Popis: | BACKGROUND: Surgical resection of pancreatic metastasis (PM) is the only reported curative treatment for renal cell carcinoma. However, there is currently little information regarding very long-term survival. The primary objective of this study was to determine the 10-year survival of this condition using the largest surgical series reported to date. METHODS: Between May 1987 and June 2003, we conducted a retrospective study of 62 patients surgically treated for PM from renal cell carcinoma at 12 Franco-Belgian surgical centers. Follow-up ended on May 31, 2012. RESULTS: There were 27 male (44 %) and 35 female (56 %) patients with a median age of 54 years [31-75]. Mean disease-free interval from resection of primary tumor to reoperation for pancreatic recurrence was 9.8 years (median 10 years [0-25]). During a median follow-up of 91 months [12-250], 37 recurrences (60 %) were observed. After surgical resection of repeated recurrences, overall median survival time was 52.6 months versus 11.2 months after nonoperative management (p = 0.019). Cumulative 3-, 5-, and 10-year overall survival (OS) rates were 72, 63, and 32 %, respectively. The corresponding disease-free survival rates were 54, 35, and 27 %, respectively. Lymph node involvement and existence of extrapancreatic metastases before PM were associated with poor overall survival. CONCLUSIONS: Aggressive surgical management of single or multiple PM, even in cases of extrapancreatic disease, should be considered in selected patients to allow a chance of long-term survival. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink